Medsider: Learn from Medtech and Healthtech Founders and CEOs

Testing Demand Before Perfecting Technology: Interview with Eyebot CEO Matthias Hofmann

16 Mar 2026

Audio

Description

In this episode of Medsider Radio, we sat down with Matthias Hofmann, CEO of Eyebot.Eyebot is commercializing retail kiosks that deliver quick, efficient vision testing.Before Eyebot, Matthias led product development at Formlabs and served as an R&D lead at EyeNetra, where he helped bring the first smartphone-based vision test to market. He holds a Ph.D. in Electrical Engineering with graduate work in vision science and optics. In this interview, Matthias discusses how early missteps informed Eyebot's strategy, how he proved demand before raising capital, and how iterative clinical studies established commercial credibility — along with his unconventional advice on fundraising.Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you’re ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Matthias Hofmann.KEY MOMENTS FROM THE INTERVIEW(02:53) - Overview of Matthias’s background and the journey that led him into vision care startups (05:58) - Lessons from solving the right problem the wrong way at EyeNetra (08:44) - Why Eyebot chose a kiosk interface instead of smartphone vision testing (11:08) - How Eyebot designed its system to deliver accurate prescriptions in about 90 seconds (18:17) - How Eyebot proved demand with a rough prototype and a “Free Vision Test” sign in a Boston mall (29:01) - How clinical studies and iteration built the evidence retailers needed to trust the technology (33:17) - What commercialization revealed about consumer behavior in eyewear retail (37:07) - Matthias’s fundraising advice: run your raise over Zoom and don’t lead with your pitch deck

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Other episodes from Medsider: Learn from Medtech and Healthtech Founders and CEOs

Transcribed and ready to explore now

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec

16 Dec 2025

Medsider: Learn from Medtech and Healthtech Founders and CEOs

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD

10 Dec 2025

Medsider: Learn from Medtech and Healthtech Founders and CEOs

View all episodes from Medsider: Learn from Medtech and Healthtech Founders and CEOs

Comments

There are no comments yet.

Please log in to write the first comment.

Report any issue

Medsider: Learn from Medtech and Healthtech Founders and CEOs

Testing Demand Before Perfecting Technology: Interview with Eyebot CEO Matthias Hofmann

This episode hasn't been transcribed yet

Other episodes from Medsider: Learn from Medtech and Healthtech Founders and CEOs

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD

Sign in to Audioscrape

Share this moment